Article info

Download PDFPDF

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
Free

Authors

  1. Correspondence to Rupesh Agrawal, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 308433, Singapore; rupesh_agrawal{at}ttsh.com.sg Carlos Pavesio, Medical Retina and Uveitis, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK; c.pavesio{at}nhs.net and Quan Dong Nguyen, Byers Eye Institute, Stanford University School of Medicine, California, USA; ndquan{at}stanford.edu
View Full Text

Citation

Agrawal R, Testi I, Lee CS COVID-19 IMT Study Group, et al
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Publication history

  • Received May 4, 2020
  • Revised May 21, 2020
  • Accepted May 26, 2020
  • First published June 25, 2020.
Online issue publication 
April 22, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.